NCT07367347

Brief Summary

This study seeks to identify the most effective neuraxial technique for labor analgesia in Class III parturient

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

January 16, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

11 months

First QC Date

January 16, 2026

Last Update Submit

January 25, 2026

Conditions

Keywords

labor analgesianeuraxial analgesiaobesityparturient

Outcome Measures

Primary Outcomes (1)

  • Success rate of labor analgesia

    The success rate of each technique will be determined by: Number of patients requiring a physician top-up bolus Block symmetry First-attempt success rate

    onset of neuraxial analgesia to completion of labor

Secondary Outcomes (2)

  • Maternal adverse events

    onset of neuraxial analgesia to completion of labor

  • Fetal adverse events

    at 1 and 5 minutes after birth

Study Arms (1)

Class III obese parturient

Class III obese parturient receiving neuraxial analgesia

Procedure: Neuraxial analgesia

Interventions

Combined spinal-epidural analgesia

Class III obese parturient

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Class III obese parturient receiving neuraxial analgesia (CSE, epidural or DPE) in labor rooms of Women's Wellness and Research Center between 1 January 2015 to 1 December 2024.

You may qualify if:

  • Age \> or equal to 18 years
  • BMI ≥ 40 kg/m²
  • Gestational age ≥ 28 weeks

You may not qualify if:

  • Age \< 18 years
  • BMI \< 40 kg/m²
  • History of venous thromboembolism or arterial disease (e.g., DVT, PE, angina, MI, or stroke)
  • Severe active lung, cardiovascular, renal, or liver disorders; autoimmune disease; or hemoglobinopathies
  • Hereditary or acquired thrombophilia (e.g., Factor V Leiden mutation or antithrombin deficiency)
  • In utero fetal demise (IUFD)
  • Failed operative vaginal delivery
  • Cesarean for the second twin or multiple pregnancies (triplets or higher)
  • IVF pregnancy
  • Intraoperative bleeding\>1500mL
  • Emergency cesarean section (Category I)
  • Presence of large uterine fibroid ≥10 cm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women's Wellness and Research Center

Doha, Qatar

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ayten Saracoglu

    University of Florida, UF Health, Jacksonville, FL 32209, USA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Resident Physician

Study Record Dates

First Submitted

January 16, 2026

First Posted

January 26, 2026

Study Start

February 2, 2025

Primary Completion

December 31, 2025

Study Completion

January 1, 2026

Last Updated

January 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations